These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15015710)

  • 21. Current therapeutic approaches in childhood chronic hepatitis B infection: a multicenter study.
    Dikici B; Ozgenc F; Kalayci AG; Targan S; Ozkan T; Selimoglu A; Doganci T; Kansu A; Tosun S; Arslan N; Kasirga E; Bosnak M; Haspolat K; Buyukgebiz B; Aydogdu S; Girgin N; Yagci RV
    J Gastroenterol Hepatol; 2004 Feb; 19(2):127-33. PubMed ID: 14731120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
    Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
    Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A practical guide to the use of interferons in the management of hepatitis virus infections.
    Saracco G; Rizzetto M
    Drugs; 1997 Jan; 53(1):74-85. PubMed ID: 9010649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta.
    Heidrich B; Yurdaydın C; Kabaçam G; Ratsch BA; Zachou K; Bremer B; Dalekos GN; Erhardt A; Tabak F; Yalcin K; Gürel S; Zeuzem S; Cornberg M; Bock CT; Manns MP; Wedemeyer H;
    Hepatology; 2014 Jul; 60(1):87-97. PubMed ID: 24585488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.
    Bourlière M; Rabiega P; Ganne-Carrie N; Serfaty L; Marcellin P; Barthe Y; Thabut D; Guyader D; Hezode C; Picon M; Causse X; Leroy V; Bronowicki JP; Carrieri P; Riachi G; Rosa I; Attali P; Molina JM; Bacq Y; Tran A; Grangé JD; Zoulim F; Fontaine H; Alric L; Bertucci I; Bouvier-Alias M; Carrat F;
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):177-188. PubMed ID: 28404133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.
    Farci P; Roskams T; Chessa L; Peddis G; Mazzoleni AP; Scioscia R; Serra G; Lai ME; Loy M; Caruso L; Desmet V; Purcell RH; Balestrieri A
    Gastroenterology; 2004 Jun; 126(7):1740-9. PubMed ID: 15188169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of patients with chronic hepatitis B.
    Liaw YF
    J Gastroenterol Hepatol; 2002 Apr; 17(4):406-8. PubMed ID: 11982720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural history of chronic hepatitis B virus infection in childhood and efficacy of interferon therapy.
    Takano T; Tajiri H; Etani Y; Miyoshi Y; Tanaka Y; Brooks S
    Scand J Gastroenterol; 2015 Jul; 50(7):892-9. PubMed ID: 25861806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon/long-term lamivudine combination therapy in anti-HBe positive chronic hepatitis B patients.
    Nikolaidis NL; Giouleme OI; Tziomalos KA; Saveriadis AS; Grammatikos N; Doukelis P; Voutsas AD; Vassiliadis T; Patsiaoura K; Orfanou-Koumerkeridou E; Balaska A; Eugenidis NP
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1721-5. PubMed ID: 16246192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic efficacy of sequential and simultaneous treatments with interferon-alpha and lamivudine in children with chronic hepatitis B.
    Akman SA; Okcu SC; Halicioğlu O; Sutcuoglu S; Anil M; Kizilgunesler A; Bakiler AR
    Pediatr Int; 2007 Dec; 49(6):848-52. PubMed ID: 18045284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B.
    Zavaglia C; Severini R; Tinelli C; Franzone JS; Airoldi A; Tempini S; Bettale G; Ideo G
    Dig Dis Sci; 2000 Apr; 45(4):690-6. PubMed ID: 10759236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lamivudine and alpha-interferon in combination long term for precore mutant chronic hepatitis B.
    Tatulli I; Francavilla R; Rizzo GL; Vinciguerra V; Ierardi E; Amoruso A; Panella C; Francavilla A
    J Hepatol; 2001 Dec; 35(6):805-10. PubMed ID: 11738109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine.
    Mansour W; Ducancelle A; Le Gal F; Le Guillou-Guillemette H; Abgueguen P; Pivert A; Calès P; Gordien E; Lunel F
    J Clin Virol; 2010 Jan; 47(1):97-9. PubMed ID: 19914127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
    Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment.
    Grabowski J; Yurdaydìn C; Zachou K; Buggisch P; Hofmann WP; Jaroszewicz J; Schlaphoff V; Manns MP; Cornberg M; Wedemeyer H;
    Liver Int; 2011 Oct; 31(9):1395-405. PubMed ID: 21762356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lamivudine treatment for chronic hepatitis B infection in children unresponsive to interferon.
    Hartman C; Berkowitz D; Shouval D; Eshach-Adiv O; Hino B; Rimon N; Satinger I; Kra-Oz T; Daudi N; Shamir R
    Pediatr Infect Dis J; 2003 Mar; 22(3):224-9. PubMed ID: 12634582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
    Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H
    J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.